Search Prime Grants

U01CA275301

Cooperative Agreement

Overview

Grant Description
B cell determinants of EBV latency.
Awardee
Weill Medical College Of Cornell University
Funding Goals
TO PROVIDE FUNDAMENTAL INFORMATION ON THE CAUSE AND NATURE OF CANCER IN PEOPLE, WITH THE EXPECTATION THAT THIS WILL RESULT IN BETTER METHODS OF PREVENTION, DETECTION AND DIAGNOSIS, AND TREATMENT OF NEOPLASTIC DISEASES. CANCER BIOLOGY RESEARCH INCLUDES THE FOLLOWING RESEARCH PROGRAMS: CANCER CELL BIOLOGY, CANCER IMMUNOLOGY, HEMATOLOGY AND ETIOLOGY, DNA AND CHROMOSOMAL ABERRATIONS, TUMOR BIOLOGY AND METASTASIS, AND STRUCTURAL BIOLOGY AND MOLECULAR APPLICATIONS.
Grant Program (CFDA)
93.396 - Cancer Biology Research
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
New York, New York 100654805 United States
Geographic Scope
Single Zip Code
Related Opportunity
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) (PAR-21-348)
Analysis Notes
Amendment Since initial award the total obligations have increased 291% from $864,001 to $3,376,443.
Weill Medical College Of Cornell University was awarded B cell determinants of EBV latency Cooperative Agreement U01CA275301 worth $3,376,443 from National Cancer Institute in September 2022 with work to be completed primarily in New York New York United States. The grant has a duration of 5 years and was awarded through assistance program 93.396 Cancer Biology Research. The Cooperative Agreement was awarded through grant opportunity The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
9/9/22
Start Date
8/31/27
End Date
64.0% Complete

Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01CA275301

Subgrant Awards

Disclosed subgrants for U01CA275301

Transaction History

Modifications to U01CA275301

Additional Detail

Award ID FAIN
U01CA275301
SAI Number
U01CA275301-1851126778
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
YNT8TCJH8FQ8
Awardee CAGE
1UMU6
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $1,691,800 100%
Modified: 9/24/25